BRPI0511793B8 - proteínas quiméricas isoladas de lumazina sintase modificada - Google Patents

proteínas quiméricas isoladas de lumazina sintase modificada

Info

Publication number
BRPI0511793B8
BRPI0511793B8 BRPI0511793A BRPI0511793A BRPI0511793B8 BR PI0511793 B8 BRPI0511793 B8 BR PI0511793B8 BR PI0511793 A BRPI0511793 A BR PI0511793A BR PI0511793 A BRPI0511793 A BR PI0511793A BR PI0511793 B8 BRPI0511793 B8 BR PI0511793B8
Authority
BR
Brazil
Prior art keywords
chimeric proteins
vaccines
antibodies
nucleotide sequences
lumazine synthase
Prior art date
Application number
BRPI0511793A
Other languages
English (en)
Inventor
Fernando A Goldbaum
Original Assignee
Goldgene Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goldgene Llc filed Critical Goldgene Llc
Publication of BRPI0511793A publication Critical patent/BRPI0511793A/pt
Publication of BRPI0511793B1 publication Critical patent/BRPI0511793B1/pt
Publication of BRPI0511793B8 publication Critical patent/BRPI0511793B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y205/00—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
    • C12Y205/01—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
    • C12Y205/01009—Riboflavin synthase (2.5.1.9)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

proteínas quiméricas isoladas de lumazina sintase modificada. a presente invenção refere-se a proteínas quiméricas isoladas incluindo até dez cópias de peptídeos, polipeptídeos ou domínios de proteína inseridas no termina amino de brucella spp. à enzima lumazina sintase. a seqüências de nucleotídeos que codificam as proteínas quiméricas. a vetores, plasmídeos e células transformadas utilizados para a expressão de proteínas. a anticorpos monoclonais e policlonais induzidos pelas proteínas quiméricas. a hibridomas que produzem os anticorpos monoclonais. a vacinas e compostos farmacêuticos incluindo as proteínas quiméricas, seqüências de nucleotídeos e anticorpos. a um método para induzir uma resposta imune em organismos superiores incluindo a administração de quantidade efetivas das vacinas e compostos farmacêuticos. a biossensores incluindo as proteínas quiméricas. a conjugados de proteína formados pelas proteínas quiméricas e um ligante ligados por meio de ligações covalentes e não covalentes. aos usos das proteínas quiméricas, seqüências de nucleotídeos, vetores, plasmídeos, células transformadas, anticorpos, hibridomas, conjugados, biossensores, vacinas e compostos farmacêuticos. à estrutura quaternária das proteínas quiméricas.
BRPI0511793A 2004-06-03 2005-06-03 proteínas quiméricas isoladas de lumazina sintase modificada BRPI0511793B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ARP040101923A AR044603A1 (es) 2004-06-03 2004-06-03 Proteinas quimericas aisladas de lumazina sintetasa modificada para la presentacion multiple de moleculas y sus aplicaciones
PCT/US2005/019289 WO2005121330A2 (en) 2004-06-03 2005-06-03 Isolated chimeric proteins of modified lumazine synthase

Publications (3)

Publication Number Publication Date
BRPI0511793A BRPI0511793A (pt) 2008-01-15
BRPI0511793B1 BRPI0511793B1 (pt) 2018-10-23
BRPI0511793B8 true BRPI0511793B8 (pt) 2021-05-25

Family

ID=35503729

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0511793A BRPI0511793B8 (pt) 2004-06-03 2005-06-03 proteínas quiméricas isoladas de lumazina sintase modificada

Country Status (10)

Country Link
US (1) US8685670B2 (pt)
EP (1) EP1776456B1 (pt)
CN (1) CN101133163B (pt)
AR (1) AR044603A1 (pt)
BR (1) BRPI0511793B8 (pt)
CA (1) CA2569401C (pt)
DK (1) DK1776456T3 (pt)
ES (1) ES2413159T3 (pt)
MX (1) MXPA06013984A (pt)
WO (1) WO2005121330A2 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014191903A1 (en) * 2013-05-27 2014-12-04 Inmunova S.A. Chimeras of brucella lumazine synthase and beta subunit of ab5 toxins
US10688175B2 (en) 2015-10-13 2020-06-23 Daniel C. Carter NSP10 self-assembling fusion proteins for vaccines, therapeutics, diagnostics and other nanomaterial applications
CN109196104B (zh) 2016-04-11 2023-01-31 生源霸科乌拉圭有限公司 用于病毒性疾病的广效型疫苗
CN106636138A (zh) * 2017-01-12 2017-05-10 李增魁 一种针对羊种3型布鲁氏菌感染的dna疫苗及其制备方法
CN112996819A (zh) * 2018-08-16 2021-06-18 纪念斯隆-凯特琳癌症中心 细胞分选系统及使用方法
WO2021014385A1 (en) 2019-07-24 2021-01-28 Glaxosmithkline Biologicals Sa Modified human cytomegalovirus proteins
CN110922488A (zh) * 2019-11-08 2020-03-27 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 一种含EB病毒gp350的自组装纳米颗粒及制备方法和应用
CN111217918B (zh) * 2020-03-04 2020-11-10 中山大学 一种基于2,4-二氧四氢喋啶合酶的新型冠状病毒s蛋白双区域亚单位纳米疫苗
WO2021245611A1 (en) 2020-06-05 2021-12-09 Glaxosmithkline Biologicals Sa Modified betacoronavirus spike proteins
CN114621352B (zh) * 2020-12-10 2024-01-23 中国科学院大连化学物理研究所 硅融合蛋白及制备和应用
CN112458054B (zh) * 2020-12-25 2023-03-31 上海纳米技术及应用国家工程研究中心有限公司 一种快速扩增体外nk细胞的方法
WO2023144665A1 (en) 2022-01-28 2023-08-03 Glaxosmithkline Biologicals Sa Modified human cytomegalovirus proteins

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4258029A (en) 1979-04-23 1981-03-24 Connaught Laboratories Limited Synthetic adjuvants for stimulation of antigenic responses
US4235877A (en) 1979-06-27 1980-11-25 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
BR9915771A (pt) 1998-11-30 2001-12-26 Cytos Biotechnology Ag Apresentação molecular ordenada de antìgenos,processo de preparação e utilização
US20040014158A1 (en) * 1999-03-08 2004-01-22 Adelbert Bacher Protein conjugates, methods, vectors, proteins and DNA for producing them, their use, and medicaments and vaccines containing a certain quantity of said protein conjugates
DE19910102B4 (de) 1999-03-08 2006-06-01 Fischer, Markus, Dr.rer.nat. Proteinkonjugate, Verfahren, Vektoren, Proteine und DNA zu deren Herstellung, deren Verwendung, sowie Arzneimittel und Impfstoffe mit einem Gehalt derselben
GB9929151D0 (en) 1999-12-09 2000-02-02 Univ Cambridge Tech Peptide and polypeptide display
WO2001085208A2 (en) 2000-05-05 2001-11-15 Cytos Biotechnology Ag Molecular antigen arrays and vaccines
US20040213808A1 (en) * 2002-12-11 2004-10-28 Michael Lieberman Recombinant vaccine against flavivirus infection

Also Published As

Publication number Publication date
CA2569401C (en) 2017-03-07
EP1776456A2 (en) 2007-04-25
EP1776456B1 (en) 2013-02-20
US8685670B2 (en) 2014-04-01
DK1776456T3 (da) 2013-05-27
US20090087435A1 (en) 2009-04-02
CN101133163B (zh) 2013-04-24
WO2005121330A3 (en) 2007-11-01
BRPI0511793A (pt) 2008-01-15
BRPI0511793B1 (pt) 2018-10-23
MXPA06013984A (es) 2007-03-01
AR044603A1 (es) 2005-09-21
ES2413159T3 (es) 2013-07-15
EP1776456A4 (en) 2008-06-18
WO2005121330A2 (en) 2005-12-22
CN101133163A (zh) 2008-02-27
CA2569401A1 (en) 2005-12-22

Similar Documents

Publication Publication Date Title
BRPI0511793B8 (pt) proteínas quiméricas isoladas de lumazina sintase modificada
US11479605B2 (en) Homodimeric protein constructs
AR075047A1 (es) Metodos y composiciones en base a la proteina tipo 2 de la toxina shiga. polipeptido purificado. anticuerpo ant-stx2. kit.
US9644020B2 (en) Human Tim-3 fusion protein capable of blocking Tim-3 signaling pathway
Tsybalova et al. Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine
WO2006045891A1 (en) Avidin-like proteins from symbiotic bacteria
CN103665155B (zh) 一种抗流感病毒广谱中和性的中和分子1f2
Klausberger et al. Globular head-displayed conserved influenza H1 hemagglutinin stalk epitopes confer protection against heterologous H1N1 virus
Mehrlatifan et al. The structural HCV genes delivered by MPG cell penetrating peptide are directed to enhance immune responses in mice model
Wirschell et al. Building a radial spoke: flagellar radial spoke protein 3 (RSP3) is a dimer
Sun et al. Localization of infection-related epitopes on the non-structural protein 3ABC of foot-and-mouth disease virus and the application of tandem epitopes
Akamatsu et al. A simple screening for mutant DNA binding proteins: application to murine transcription factor PEBP2α subunit, a founding member of the Runt domain protein family
Edinger et al. Targeting polyIC to EGFR over-expressing cells using a dsRNA binding protein domain tethered to EGF
Hey et al. A two fusion partner system for raising antibodies against small immunogens expressed in bacteria
Kondo et al. Efficient delivery of antibody into living cells using a novel HVJ envelope vector system
CN103360497A (zh) 一种新型抗肿瘤融合蛋白疫苗及其制备方法和应用
Li et al. Recombinant protein comprising multi-neutralizing epitopes induced high titer of antibodies against influenza A virus
Dunn et al. Fine mapping of the binding sites of monoclonal antibodies raised against the Pk tag
Kim et al. Built‐in RNA‐mediated chaperone (chaperna) for antigen folding tailored to immunized hosts
CN104630172B (zh) 一种血吸虫谷胱甘肽‑s‑转移酶的突变体及其应用
CN103665153A (zh) 一种抗流感病毒广谱中和性的中和分子1e1
Fang et al. Immunogenicity of Recombinant Maltose-binding Protein (MBP)–Gonadotropin Releasing Hormone I (GnRH-I)
KR102259974B1 (ko) 재조합 항원을 이용하여 목적 항원 특이적인 항체를 제조하는 방법
De Re et al. Characterization of Antibodies Directed against the Immunoglobulin Light κ Chain Variable Chain Region (VK) of Hepatitis C Virus‐Related Type‐II Mixed Cryoglobulinemia and B‐Cell Proliferations
Aliev et al. Development and properties of recombinant proteins based on the broadly neutralizing antibody to influenza A virus

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: A CLASSIFICACAO ANTERIOR ERA: C12N 9/06

Ipc: C12N 9/10 (2006.01), C12N 15/54 (2006.01), A61K 38

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/10/2018, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/06/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF